{"id":58192,"date":"2023-10-11T01:01:07","date_gmt":"2023-10-10T23:01:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/"},"modified":"2023-10-11T01:01:07","modified_gmt":"2023-10-10T23:01:07","slug":"cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/","title":{"rendered":"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care"},"content":{"rendered":"
\n

\nCII will continue all operations, including its supervision program, and bolster its compliance program under a Corporate Integrity Agreement with the Office of Inspector General.<\/p>\n

<\/a>
<\/a><\/p>\n

OAKBROOK TERRACE, Ill.–(BUSINESS WIRE)–Cardiac Imaging, Inc. (\u201cCII\u201d or the \u201cCompany\u201d) announced it has fully resolved an investigation by the U.S. Department of Justice (the \u201cDOJ\u201d) related to the fair market value of payments made to physicians for supervising cardiac PET and PET\/CT scans. CII fully cooperated with the DOJ\u2019s investigation, the resolution of which allows the Company to continue to move forward with its core mission of providing the leading cardiac imaging technology and care to patients across the US.<\/p>\n

\n\u201cWe are pleased to reach the resolution announced today, and CII will continue to service patients across the nation with our fixed and mobile solutions, including our supervision program,\u201d said Sam Kancherlapalli, Chief Executive Officer. \u201cCII remains deeply committed to providing patients with the leading cardiac care, and we\u2019re excited to continue to drive our mission forward.\u201d<\/p>\n

\nAs is common in settlements of this nature, CII has entered into a five-year Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services (HHS-OIG), and HHS-OIG agreed to waive its permissive exclusion authority for the conduct covered by the settlement agreement.<\/p>\n

\nCardiac Imaging, Inc. denies the allegations in the settlement agreement, and the settlement agreement is not an admission of liability by CII. The allegations did not pertain to the quality, medical need, or performance of CII\u2019s services.<\/p>\n

\nAbout Cardiac Imaging, Inc.<\/span><\/p>\n

\nCardiac Imaging, Inc. is the nation\u2019s leading provider of cardiac PET services through their mobile and fixed site services. Their cutting-edge fleet of mobile coaches delivers all-inclusive Cardiac PET\/CT imaging services straight to cardiologists\u2019 offices. Cardiac Imaging, Inc.\u2019s fixed site program is a comprehensive turnkey offering, enabling physicians to administer cardiac PET in their own facilities. Through these solutions, Cardiac Imaging, Inc. is advancing the field of cardiac PET and delivering premier cardiac care across the US.<\/p>\n

\nRelated Links
\n
https:\/\/www.mobilecardiacpet.com\/<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nJennifer Willekes
\n
Chief Compliance Officer
\n
jwillekes@cardiacscan.org<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CII will continue all operations, including its supervision program, and bolster its compliance program under a Corporate Integrity Agreement with the Office of Inspector General. OAKBROOK TERRACE, Ill.–(BUSINESS WIRE)–Cardiac Imaging, Inc. (\u201cCII\u201d or the \u201cCompany\u201d) announced it has fully resolved an investigation by the U.S. Department of Justice (the \u201cDOJ\u201d) related to the fair market … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58192","6":"format-standard","7":"category-industry"},"yoast_head":"\nCII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CII will continue all operations, including its supervision program, and bolster its compliance program under a Corporate Integrity Agreement with the Office of Inspector General. OAKBROOK TERRACE, Ill.–(BUSINESS WIRE)–Cardiac Imaging, Inc. (\u201cCII\u201d or the \u201cCompany\u201d) announced it has fully resolved an investigation by the U.S. Department of Justice (the \u201cDOJ\u201d) related to the fair market ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-10T23:01:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231010294716\/en\/1912032\/21\/Cardiac-Imaging-Mark-RGB-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care\",\"datePublished\":\"2023-10-10T23:01:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/\"},\"wordCount\":372,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010294716\\\/en\\\/1912032\\\/21\\\/Cardiac-Imaging-Mark-RGB-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/\",\"name\":\"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010294716\\\/en\\\/1912032\\\/21\\\/Cardiac-Imaging-Mark-RGB-01.jpg\",\"datePublished\":\"2023-10-10T23:01:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010294716\\\/en\\\/1912032\\\/21\\\/Cardiac-Imaging-Mark-RGB-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010294716\\\/en\\\/1912032\\\/21\\\/Cardiac-Imaging-Mark-RGB-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/","og_locale":"en_US","og_type":"article","og_title":"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care - Pharma Trend","og_description":"CII will continue all operations, including its supervision program, and bolster its compliance program under a Corporate Integrity Agreement with the Office of Inspector General. OAKBROOK TERRACE, Ill.–(BUSINESS WIRE)–Cardiac Imaging, Inc. (\u201cCII\u201d or the \u201cCompany\u201d) announced it has fully resolved an investigation by the U.S. Department of Justice (the \u201cDOJ\u201d) related to the fair market ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/","og_site_name":"Pharma Trend","article_published_time":"2023-10-10T23:01:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231010294716\/en\/1912032\/21\/Cardiac-Imaging-Mark-RGB-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care","datePublished":"2023-10-10T23:01:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/"},"wordCount":372,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231010294716\/en\/1912032\/21\/Cardiac-Imaging-Mark-RGB-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/","url":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/","name":"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231010294716\/en\/1912032\/21\/Cardiac-Imaging-Mark-RGB-01.jpg","datePublished":"2023-10-10T23:01:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231010294716\/en\/1912032\/21\/Cardiac-Imaging-Mark-RGB-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231010294716\/en\/1912032\/21\/Cardiac-Imaging-Mark-RGB-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cii-resolves-allegations-with-no-admission-of-liability-affirms-commitment-to-accessible-cardiac-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CII Resolves Allegations with No Admission of Liability; Affirms Commitment to Accessible Cardiac Care"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58192"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58192\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}